Wealth Enhancement Advisory Services, LLC Amgen Inc Transaction History

Wealth Enhancement Advisory Services, LLC

$46.2 Billion
Q4 2024

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 504,280 shares of AMGN stock, worth $137 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

504,280

Previous 325,976 54.7%

Holding current value

$137 Million

Previous $105 Million 25.14%

% of portfolio

0.28%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 10, 2025	BUY	$258.78 - $328.31 $46.1 Million - $58.5 Million	178,304 Added 54.7%	504,280 $131 Million
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $4.86 Million - $5.3 Million	-15,702 Reduced 4.6%	325,976 $105 Million
Q2 2024 Jul 16, 2024	BUY	$262.75 - $319.31 $3.89 Million - $4.73 Million	14,812 Added 4.53%	341,678 $107 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $5.12 Million - $6.18 Million	19,029 Added 6.18%	326,866 $92.9 Million
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $2.59 Million - $2.93 Million	10,146 Added 3.41%	307,837 $88.7 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $64.7 Million - $80.4 Million	296,057 Added 18118.54%	297,691 $80 Million
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $5.16 Million - $6.1 Million	-24,079 Reduced 93.65%	1,634 $362,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $5.62 Million - $6.85 Million	24,888 Added 3016.73%	25,713 $6.22 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $188,949 - $240,083	825 New	825 $216,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $12.3 Million - $13.7 Million	53,352 Added 6254.63%	54,205 $13.5 Million
Q1 2022 Apr 18, 2022	BUY	$219.27 - $242.57 $187,037 - $206,912	853 New	853 $209,000
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $3.98 Million - $4.41 Million	-17,023 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $113,396 - $132,144	511 Added 3.09%	17,023 $4.24 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $3.57 Million - $4.25 Million	16,512 New	16,512 $4.05 Million
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $3.63 Million - $4.82 Million	-19,937 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $947,752 - $1.22 Million	5,009 Added 33.55%	19,937 $4.81 Million
Q3 2019 Nov 06, 2019	BUY	$174.11 - $208.62 $2.6 Million - $3.11 Million	14,928 New	14,928 $3 Million
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $1.32 Million - $1.54 Million	-7,893 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $1.43 Million - $1.61 Million	-7,915 Reduced 50.07%	7,893 $1.42 Million
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $348,058 - $406,295	-1,951 Reduced 10.99%	15,808 $3.22 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $3.29 Million - $3.71 Million	17,759 New	17,759 $3.34 Million
Q4 2017 Jan 19, 2018	SELL	$168.79 - $188.59 $873,825 - $976,330	-5,177 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$167.29 - $191.0 $866,060 - $988,807	5,177	5,177 $962,000

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Amgen Inc Transaction History